To further interrogate the Fbxo4–Fxr1 regulatory axis in human head and neck cancer, serial sections of tissue microarrays (TMAs) with 36-paired normal and tumour tissue cores were used for immunohistochemical (IHC) staining and pathological assessment (Fig. 5a). The gene discussed is FBXO4; the disease is head and neck cancer.